new glp 1 agonist for weight loss Retatrutide loss: Study shows 30% body weight What are GLP-1s? | Mendinground

It targets GLP-1, GIP, and glucagon receptors simultaneously, adding a third mechanism that directly increases energy expenditure and fat oxidation through the liver

Additionally, the loss of muscle mass has been problematic for some individuals taking this class of medication, with lean body mass accounting for up to 1540% of total weight loss

The definition of an ocular complication also varied in severity

[4] These gastrointestinal symptoms are often mild to moderate in severity and tend to diminish over time as the body adjusts to the medication

Moreover, studies highlight its potential cardiovascular benefits